|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/7115 | (2006.01) |
| C07K 16/244 | (2013.01) | ||
| A61K 39/39 | (2006.01) | ||
| A61K 45/06 | (2013.01) | ||
| A61K 45/06 | (2006.01) | ||
| C07K 16/2818 | (2013.01) | ||
| A61K 9/00 | (2006.01) | ||
| C07K2317/76 | (2013.01) | ||
| A61N 5/00 | (2006.01) | ||
| A61K 31/7115 | (2013.01) | ||
| C07K 14/435 | (2006.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61P 35/00 | (2006.01) | ||
| C07K 14/435 | (2013.01) | ||
| A61K2039/505 | (2013.01) | ||
| A61K2039/55561 | (2013.01) |
| (11) | Patento numeris | 3302501 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 16804054.1 |
| Europos patento paraiškos padavimo data | 2016-05-26 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-04-11 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-09-22 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2016/034275 |
| Data | 2016-05-26 |
| (87) | Numeris | WO 2016/196173 |
| Data | 2016-12-08 |
| (30) | Numeris | Data | Šalis |
| 201562168449 P | 2015-05-29 | US | |
| 201562169309 P | 2015-06-01 | US |
| (72) |
YU, Ying , US
DENKER, Andrew Evan , US
SADEKOVA, Svetlana , US
PHAN, Uyen Truong , US
KASTELEIN, Robert A. , US
KAUFMAN, David Ross , US
COFFMAN, Robert L. , US
GUIDUCCI, Cristiana , US
JANSSEN, Robert S. , US
|
| (73) |
Merck Sharp & Dohme Corp. ,
126 East Lincoln Avenue, Rahway, NJ 07065-0907,
US
Surefire Medical, Inc. , d/b/a TriSalus Life Sciences 6272 West 91st Avenue, Westminster, CO 80031, US |
| (54) | COMBINATION OF A PD-1 ANTAGONIST AND CPG-C TYPE OLIGONUCLEOTIDE FOR TREATING CANCER |
| COMBINATION OF A PD-1 ANTAGONIST AND CPG-C TYPE OLIGONUCLEOTIDE FOR TREATING CANCER |